Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin
Abstract
This paper has been withdrawn.
Skip to main content
Browse
- Research Centers and Departments
- Conferences and Events
- Disciplines
- Student Work
- Open Educational Resources
For Authors
Scholarly Communication
- 435-797-0816
Research Data
- 435-797-2632
- Research Data Management Services @ USU
